A dysprothrombin designated prothrombin Segoviawas isolatedfrom the plasmaof an individual withnormal prothrombin antigen andprothrombin activity lesserthan25°Aof the control prothrombin activity.Activationby prothrombinase complex showed a lower amidolytic thanclottingactivity, whichsuggests a lessergeneration of activeintermediates thannormalprothrombin. Whenprothrombin Segoviawas activated by protbrombinase complexm the absenceof iktor Va, no tbrombinformationwas found by fictional activities. SDS-PAGEanalysis of themolecules derived by activation withprotbrombrnase comple> Taipansnakevenom andEchis carinafusvenom showedan accumulation of molecules not cleavedatbondArg320-lle321. Ihis wasmoreevident withEchiscarinutus veno~whichonlyactson thisbond.Ourdatasuggestthatthealteration of prothrombin Segoviaimpairs thescission of bondArg320-Ile321. Q1997ElsevierScience.QdDysprothrombinemias represent oneof themostuncommoncoagulation defects; so fir, 21variantsj all of them charactetid by a decreasem the fictional level of prothrombincomparedto the immunologically detectable prothrombin (l), have beenreported (2-7).The conversionof humanprothrombin to thrombrn requirestwo cleavages(8): one at bond A (Arg271-Thr272), thatsplitsprothrombin rntofragment1+2 (F1+2) andprethrombin 2 (P2), and another atbondB (Arg320-lle321), whichexposesthe activesite(9) andyieldsthe disulfide-linked two-chain (A andB chains) enzyme thrombin. Thesecleavages canbe producedm theoppositeorder, yieldingfirst the disulfiddinkedtwo-chainactiveintermediate meizothrombin (MT), and thq tbrombin. Thereare alsotwo morepeptidebondssusceptible to autocatalysis; bond C (Arg155-Ser156), and bondD, (Arg286-Thr287). Cleavage of bondC fromprothrombin producesprethrombin
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.